Crewe Clair, Schafer Christopher, Lee Irene, Kinter Michael, Szweda Luke I
From the Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma 73104.
the Department of Biochemistry and Molecular Biology, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma 73104, and.
J Biol Chem. 2017 Jan 6;292(1):305-312. doi: 10.1074/jbc.M116.754127. Epub 2016 Nov 17.
Cardiac metabolic inflexibility is driven by robust up-regulation of pyruvate dehydrogenase kinase 4 (PDK4) and phosphorylation-dependent inhibition of pyruvate dehydrogenase (PDH) within a single day of feeding mice a high fat diet. In the current study, we have discovered that PDK4 is a short lived protein (t ∼ 1 h) and is specifically degraded by the mitochondrial protease Lon. Lon does not rapidly degrade PDK1 and -2, indicating specificity toward the PDK isoform that is a potent modulator of metabolic flexibility. Moreover, PDK4 degradation appears regulated by dissociation from the PDH complex dependent on the respiratory state and energetic substrate availability of mouse heart mitochondria. Finally, we demonstrate that pharmacologic inhibition of PDK4 promotes PDK4 degradation in vitro and in vivo These findings reveal a novel strategy to manipulate PDH activity by selectively targeting PDK4 content through dissociation and proteolysis.
在给小鼠喂食高脂肪饮食的一天内,心脏代谢灵活性下降是由丙酮酸脱氢酶激酶4(PDK4)的强烈上调以及丙酮酸脱氢酶(PDH)的磷酸化依赖性抑制所驱动的。在当前研究中,我们发现PDK4是一种寿命较短的蛋白质(半衰期约为1小时),并且会被线粒体蛋白酶Lon特异性降解。Lon不会快速降解PDK1和PDK2,这表明其对作为代谢灵活性有效调节因子的PDK亚型具有特异性。此外,PDK4的降解似乎受与PDH复合物解离的调节,这取决于小鼠心脏线粒体的呼吸状态和能量底物可用性。最后,我们证明对PDK4的药理抑制在体外和体内均能促进PDK4的降解。这些发现揭示了一种通过解离和蛋白水解选择性靶向PDK4含量来操纵PDH活性的新策略。